Chris Garratt

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 3

Top Topics

Clinical Practice

Circulating Tumor

Top Venues

JCO precision oncology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Emmanuel S Antonarakis, Nicole Zhang, Jayati Saha, Liina Nevalaita, Tarja Ikonen, L Jill Tsai, Chris Garratt, Karim Fizazi
Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
Emmanuel S Antonarakis, Nicole Zhang, Jayati Saha, Liina Nevalaita, Tarja Ikonen, L Jill Tsai, Chris Garratt, Karim Fizazi
Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
Mary Weatherall, Riku Aantaa, Giorgio Conti, Chris Garratt, Pasi Pohjanjousi, Michael A Lewis, Nicholas Moore, Susana Perez-Gutthann
A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU. British journal of clinical pharmacology 83 (9) (2017)